anexate
pharmaco (nz) ltd - flumazenil 0.1 mg/ml; - solution for injection - 0.5 mg/5ml - active: flumazenil 0.1 mg/ml excipient: acetic acid edetic acid sodium chloride sodium hydroxide water for injection - latest regulatory activity
minirin
pharmaco (nz) ltd - desmopressin acetate trihydrate 0.1mg equivalent to 0.089 mg desmopressin free base - nasal spray solution - 10 mcg/dose - active: desmopressin acetate trihydrate 0.1mg equivalent to 0.089 mg desmopressin free base excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate dihydrate sodium chloride water for injection
xenical
pharmaco (nz) ltd - orlistat 120mg; ; - capsule - 120 mg - active: orlistat 120mg excipient: gelatin indigo carmine microcrystalline cellulose povidone purified talc sodium laurilsulfate sodium starch glycolate tekprint black sw-9008 titanium dioxide - xenical is for weight control, including weight loss, weight maintenance and prevention of weight regain in adults with an initial body mass index (bmi) of 30 or more. xenical should be used in conjunction with a low fat, calorie controlled diet.
konakion mm
pharmaco (nz) ltd - phytomenadione 10 mg/ml - solution for injection - 10 mg/ml - active: phytomenadione 10 mg/ml excipient: glycocholic acid hydrochloric acid lecithin sodium hydroxide water for injection
konakion mm paediatric
pharmaco (nz) ltd - phytomenadione 10 mg/ml - solution for injection - 10 mg/ml - active: phytomenadione 10 mg/ml excipient: glycocholic acid hydrochloric acid lecithin sodium hydroxide water for injection
cervidil
pharmaco (nz) ltd - dinoprostone 10mg; - pessary - 10 mg - active: dinoprostone 10mg excipient: hydrogel texturised polyester yarn retrieval system - cervical ripening in patients, at or near term, who have favourable induction features and in whom there is a medical or obstetrical indication for induction of labour.
minirin
pharmaco (nz) ltd - desmopressin acetate trihydrate 100 µg/ml equivalent to 8 9µg/ml desmopressin free base - nasal drops - 100 mcg/ml - active: desmopressin acetate trihydrate 100 µg/ml equivalent to 8 9µg/ml desmopressin free base excipient: chlorobutanol hemihydrate hydrochloric acid purified water sodium chloride - minirin nasal drops solution is indicated for the treatment of central diabetes insipidus and for establishing renal concentration capacity testing.
minirin
pharmaco (nz) ltd - desmopressin acetate trihydrate 4 µg/ml equivalent to 3.56 µg/ml desmopressin base - solution for injection - 4 mcg/ml - active: desmopressin acetate trihydrate 4 µg/ml equivalent to 3.56 µg/ml desmopressin base excipient: hydrochloric acid sodium chloride water for injection - · treatment of central diabetes insipidus and for establishing renal concentration capacity testing.
utrogestan
pharmaco (nz) ltd - progesterone 100mg; ; progesterone 100mg; progesterone 100mg; progesterone 100mg - capsule - 100 mg - active: progesterone 100mg excipient: arachis oil gelatin glycerol soya oil titanium dioxide active: progesterone 100mg excipient: gelatin glycerol purified water soya oil sunflower oil titanium dioxide active: progesterone 100mg excipient: gelatin glycerol purified water soya oil sunflower oil titanium dioxide active: progesterone 100mg excipient: gelatin glycerol purified water soya oil sunflower oil titanium dioxide - adjunctive use with an oestrogen in postmenopausal women with an intact uterus (for hormone replacement therapy [hrt]).
utrogestan
pharmaco (nz) ltd - progesterone 200mg; ; progesterone 200mg; progesterone 200mg - capsule - 200 mg - active: progesterone 200mg excipient: gelatin glycerol purified water soya oil sunflower oil titanium dioxide active: progesterone 200mg excipient: gelatin glycerol purified water soya oil sunflower oil titanium dioxide active: progesterone 200mg excipient: gelatin glycerol purified water soya oil sunflower oil titanium dioxide - oral route: hormone replacement therapy - adjunctive use with an oestrogen in postmenopausal women with an intact uterus (for hormone replacement therapy [hrt]). vaginal route: luteal phase support - supplementation of the luteal phase during assisted reproductive technology (art) cycles.